msa101

Matthew S. Austin, MD

Contact Dr. Austin

925 Chestnut Street
5th Floor
Philadelphia, PA 19107

(267) 339-3500
(800) 321-9999 fax

Most Recent Peer-reviewed Publications

  1. What is the Level of Evidence Substantiating Commercial Payers’ Coverage Policies for Total Joint Arthroplasty?
  2. Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues
  3. Staging Total Hip and Knee Arthroplasty Procedures Within 90 Days Increases Costs in Bundled Payment Programs
  4. Routine Postoperative Chemistry Panels Are Not Necessary for Most Total Joint Arthroplasty Patients
  5. Pre-Operative Urodynamic Assessment Has Poor Predictive Value for Developing Post-Operative Urinary Retention
  6. Risk Adjustment for Episode-of-Care Costs After Total Joint Arthroplasty: What is the Additional Cost of Individual Comorbidities and Demographics?
  7. From Winners to Losers: The Methodology of Bundled Payments for Care Improvement Advanced Disincentivizes Participation in Bundled Payment Programs
  8. Canceled Total Joint Arthroplasty: Who, What, When, and Why?
  9. Medicare Total Knee Arthroplasty Patients Need Not Stay 2 Midnights for Full Facility Reimbursement
  10. A Postdischarge Multimodal Pain Management Cocktail Following Total Knee Arthroplasty Reduces Opioid Consumption in the 30-Day Postoperative Period: A Group-Randomized Trial
  11. Are We at the Bottom? BPCI Programs Now Disincentivize Providers Who Maintain Quality Despite Caring for Increasingly Complex Patients
  12. Response to Letter to the Editor on “Formal Physical Therapy Following Total Hip and Knee Arthroplasty Incurs Additional Cost Without Improving Outcomes”
  13. Formal Physical Therapy Following Total Hip and Knee Arthroplasty Incurs Additional Cost Without Improving Outcomes
  14. Trends in Leadership at Orthopedic Surgery Adult Reconstruction Fellowships
  15. Substantial Preoperative Work Is Unaccounted for in Total Hip and Knee Arthroplasty
  16. Assessment of a Satisfaction Measure for Use After Primary Total Joint Arthroplasty
  17. Personal Protective Equipment: Current Best Practices for Orthopedic Teams
  18. Overlapping Surgery Increases Operating Room Efficiency Without Adversely Affecting Outcomes in Total Hip and Knee Arthroplasty
  19. Traditional Risk Factors and Logistic Regression Failed to Reliably Predict a “Bundle Buster” After Total Joint Arthroplasty
  20. A Randomized Trial of Static and Articulating Spacers for the Treatment of Infection Following Total Knee Arthroplasty
  21. The Knee Society 2020 John N. Insall Award: Removal of total knee arthroplasty from the inpatient-only list adversely affects bundled payment programmes
  22. Mepivacaine versus bupivacaine spinal anesthesia for early postoperative ambulation: A randomized controlled trial
  23. Quantifying the Perioperative Work Associated With Total Hip and Knee Arthroplasty: The Burden Has Increased With Contemporary Care Pathways
  24. Tourniquet Use Does Not Affect Functional Outcomes or Pain after Total Knee Arthroplasty: A Prospective, Double-Blinded, Randomized Controlled Trial
  25. Cluster-Randomized Trial of Opiate-Sparing Analgesia after Discharge from Elective Hip Surgery